Literature DB >> 26684913

Implantation of a Tissue-Engineered Neo-Bile Duct in Domestic Pigs.

Benjamin Struecker1, Karl-Herbert Hillebrandt, Nathanael Raschzok, Korinna Jöhrens, Antje Butter, Peter Tang, Andreas Andreou, Hendrik Napierala, Anja Reutzel-Selke, Timm Denecke, Johann Pratschke, Igor Maximilian Sauer.   

Abstract

BACKGROUND: Extrahepatic bile duct injuries remain severe complications during cholecystectomies and often require reconstruction by bilioenteric anastomosis (i.e., hepaticojejunostomy), which comes with further long-term complications (e.g., recurring ascending cholangitis, secondary biliary cirrhosis). In the case of inherent extrahepatic biliary atresia or during liver transplant, artificial or engineered bile ducts could allow novel surgical strategies without the need for hepaticojejunostomy.
METHODS: We present data on the implantation of in vitro-generated neo-bile ducts in 5 domestic pigs. The neo-bile ducts were engineered through decellularization of allogeneic blood vessels and recellularization with autologous cholangiocytes. On postoperative days 0, 1, 7, and 14, blood samples were taken and analyzed (aspartate aminotransferase, alanine aminotransferase, bilirubin, alkaline phosphatase, creatinine, and leukocytes). Magnetic resonance cholangiopancreatography was performed on postoperative day 14 on 1 pig. Fourteen days after implantation, the pigs were sacrificed and the bile ducts were explanted.
RESULTS: All pigs survived the complete study period without severe complications. None of the pigs showed signs of biliary leakage or peritonitis. The neo-bile ducts were infiltrated by neutrophils, and neoangiogenesis was observed around and into the implanted tissue.
CONCLUSION: We present a novel strategy for extrahepatic bile duct replacement by implantation of an autologous neo-bile duct generated ex vivo. Whether the presented technique allows the long-term replacement of native bile ducts must be further evaluated.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26684913     DOI: 10.1159/000441720

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  6 in total

1.  Liver scaffolds obtained by decellularization: A transplant perspective in liver bioengineering.

Authors:  Marlon Lemos Dias; Bruno Andrade Paranhos; Regina Coeli Dos Santos Goldenberg
Journal:  J Tissue Eng       Date:  2022-06-20       Impact factor: 7.940

2.  Repopulation of intrahepatic bile ducts in engineered rat liver grafts.

Authors:  Yibin Chen; Julie Devalliere; Beyza Bulutoglu; Martin L Yarmush; Basak E Uygun
Journal:  Technology (Singap World Sci)       Date:  2019-06-28

3.  Bile duct reconstruction using scaffold-free tubular constructs created by Bio-3D printer.

Authors:  Takashi Hamada; Anna Nakamura; Akihiko Soyama; Yusuke Sakai; Takayuki Miyoshi; Shun Yamaguchi; Masaaki Hidaka; Takanobu Hara; Tota Kugiyama; Mitsuhisa Takatsuki; Akihide Kamiya; Koichi Nakayama; Susumu Eguchi
Journal:  Regen Ther       Date:  2021-02-24       Impact factor: 3.419

Review 4.  Progress and Current Limitations of Materials for Artificial Bile Duct Engineering.

Authors:  Qiqi Sun; Zefeng Shen; Xiao Liang; Yingxu He; Deling Kong; Adam C Midgley; Kai Wang
Journal:  Materials (Basel)       Date:  2021-12-06       Impact factor: 3.623

5.  Scaffolds obtained from decellularized human extrahepatic bile ducts support organoids to establish functional biliary tissue in a dish.

Authors:  Jorke Willemse; Floris J M Roos; Iris J Voogt; Ivo J Schurink; Marcel Bijvelds; Hugo R de Jonge; Luc J W van der Laan; Jeroen de Jonge; Monique M A Verstegen
Journal:  Biotechnol Bioeng       Date:  2020-11-09       Impact factor: 4.530

6.  Cholangiocyte organoids from human bile retain a local phenotype and can repopulate bile ducts in vitro.

Authors:  Floris J M Roos; Haoyu Wu; Jorke Willemse; Ruby Lieshout; Laura A Muñoz Albarinos; Yik-Yang Kan; Jan-Werner Poley; Marco J Bruno; Jeroen de Jonge; Richard Bártfai; Hendrik Marks; Jan N M IJzermans; Monique M A Verstegen; Luc J W van der Laan
Journal:  Clin Transl Med       Date:  2021-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.